Oral delivery of therapeutic proteins by engineered bacterial type zero secretion system
Abstract Genetically engineered commensal bacteria are promising living drugs, however, their therapeutic molecules are frequently confined to their colonization sites. Herein, we report an oral protein delivery technology utilizing an engineered bacterial type zero secretion system (T0SS) via outer...
Saved in:
| Main Authors: | Xu Gong, Shan Liu, Bozhang Xia, Yichen Wan, Shuyi Zhang, Baoyan Zhang, Zehao Wang, Junge Chen, Fei Xiao, Xing-Jie Liang, Yun Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-02-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-57153-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanocoated bacterial carriers enhance oral bacteriophage delivery efficiency
by: Yingui Cao, et al.
Published: (2025-08-01) -
Cytosolic delivery of monobodies using the bacterial type III secretion system inhibits oncogenic BCR: ABL1 signaling
by: Chiara Lebon, et al.
Published: (2024-10-01) -
Modulation of host ATP levels by secreted bacterial effectors
by: Chunlin He, et al.
Published: (2025-05-01) -
Engineered probiotic-mediated intratumoral delivery and controlled release of bacterial collagenase for cancer therapy
by: Hong-Rui Li, et al.
Published: (2025-03-01) -
Journey to zero serious bacterial prosthetic joint infection
by: Mette Walberg, et al.
Published: (2021-11-01)